STOCK TITAN

ALX Oncology: Coastlands Capital reports 5.34% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

ALX Oncology Holdings Inc. is the issuer in a Schedule 13G in which Coastlands Capital LP (investment adviser), Coastlands Capital Partners LP (the Partnership), Coastlands Capital GP LLC (the Partnership’s general partner), Coastlands Capital LLC (Coastlands Capital LP’s general partner), and control person Matthew D. Perry each report beneficial ownership of 6,906,783 common shares, or 5.34% of the class.

The shares are held directly by Coastlands Capital Partners LP for its investors. The reporting persons report shared voting and dispositive power and disclaim beneficial ownership except to the extent of their pecuniary interests. The calculation uses 129,274,568 shares outstanding as of November 9, 2026.

Reported beneficial ownership 6,906,783 shares Each reporting person reports this same amount; the shares are held directly by Coastlands Capital Partners LP.
Percent of class 5.34% Reported by each reporting person.
Shares outstanding 129,274,568 shares Common Stock outstanding as of November 9, 2026.
beneficial ownership regulatory
"calculation of the beneficial ownership"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 6,906,783.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power regulatory
"Shared Dispositive Power 6,906,783.00"
pecuniary interest financial
"except to the extent of that person's pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALXO shares do the reporting persons report owning?

Coastlands Capital LP, Coastlands Capital Partners LP, Coastlands Capital GP LLC, Coastlands Capital LLC, and control person Matthew D. Perry each report 6,906,783 shares, or 5.34% of the class. The shares are held directly by Coastlands Capital Partners LP for its investors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





00166B105

(CUSIP Number)
11/12/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 129,274,568 shares of Common Stock outstanding as of November 9, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on November 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 129,274,568 shares of Common Stock outstanding as of November 9, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on November 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 129,274,568 shares of Common Stock outstanding as of November 9, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on November 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 129,274,568 shares of Common Stock outstanding as of November 9, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on November 16, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of shares of Common Stock held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on 129,274,568 shares of Common Stock outstanding as of November 9, 2026, as disclosed in the Quarterly Report on Form 10-Q filed by the Issuer on November 16, 2026.


SCHEDULE 13G



Coastlands Capital LP
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital LLC
Date:11/19/2026
Coastlands Capital Partners LP
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Date:11/19/2026
Coastlands Capital GP LLC
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:11/19/2026
Coastlands Capital LLC
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:11/19/2026
Matthew D. Perry
Signature:/s/ Matthew D. Perry
Name/Title:Reporting Person
Date:11/19/2026
Exhibit Information

Exhibit 99.1 - Agreement Regarding Joint Filing of Statement on Schedule 13D or 13G

Keep reading